Defiance Nasdaq Junior Biotechnology ETF (IBBJ) Research
This investment vehicle's primary objective is to track the overall performance, measured by total return, of the NASDAQ Junior Biotechnology Index, before accounting for any associated fees or expenses. The index itself is a rule-based compilation of U.S.-listed small-capitalization ("junior") biotechnology companies, carefully selected from the broader spectrum of businesses found within the NASDAQ Biotechnology Index. The fund typically implements a "replication" investment strategy, which means it generally acquires positions in all the component securities of its benchmark index, aiming to maintain their proportional weightings. This fund is designated as non-diversified.
Market snapshot
- Symbol
- IBBJ
- Price
- $29.87
- Day change
- -0.07%
- Market cap
- $8.2M
- 52-week range
- 27.85-41.45
- Sector
- Financial Services
- Industry
- Asset Management
Peer companies
- ETRACS Alerian Midstream Energy High Dividend Index ETN (AMND)
- Morgan Creek-Exos Active SPAC Arbitrage ETF (CSH)
- Euclid Capital Growth ETF (EUCG)
- ProShares Managed Futures Strategy ETF (FUT)
- Innovator IBD ETF Leaders ETF (LDRS)
- Invesco Russell 1000 Low Volatility Factor ETF (OVOL)
- Invesco Dynamic Retail ETF (PMR)
- Direxion Russell Large Over Small Cap ETF (RWLS)
Open Defiance Nasdaq Junior Biotechnology ETF (IBBJ) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.